ArticleJournal of molecular and cellular cardiology2019

C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.

Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.